AAAAAA
Results:
1-15
|
Results: 15
Authors:
BAKER J
BLEIBERG H
HUTCHISON G
JACKMAN A
KERR D
LABIANCA R
MACDONALD J
MEYER HJ
MINSKY B
NORDLINGER B
ROUGIER P
SMITS S
SOBRERO A
TAYLOR I
VERWEIJ J
Citation: J. Baker et al., AN INTERNATIONAL MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF ADVANCED COLORECTAL-CANCER (FIRST OF 2 PARTS) (REPRINTED FROM EUR-J-SURG-ONCOL, VOL 23, SUPPL A, AUGUST 1997), Annales chirurgiae et gynaecologiae, 87(3), 1998, pp. 255-264
Authors:
WILS J
SAHMOUD T
SOBRERO A
BLEIBERG H
AHMEDZAI S
BLAZEBY J
BLIJHAM G
CONROY T
CUNNINGHAM D
CURRAN D
DIAZRUBIO E
DUCREUX M
EVANS J
GLIMELIUS B
HUTCHINSON G
KERR D
KIEBERT G
KOHNE H
LABIANCA R
LANGENDIJK R
NITTI D
NORDLINGER B
ROUGIER P
SCHEITHAUER W
SCHMOLL HJ
VANCUTSEM E
WAGENER T
WILKE J
MARINUS A
THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
Authors:
ASCHELE C
GUGLIELMI A
FRASSINETI GL
MILANDRI C
AMADORI D
LABIANCA R
VINCI M
TIXI L
CAROTI C
CIFERRI E
VERDI E
ROSSO R
SOBRERO A
Citation: C. Aschele et al., SCHEDULE-SELECTIVE BIOCHEMICAL MODULATION OF 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER - A MULTICENTRIC PHASE-II STUDY, British Journal of Cancer, 77(2), 1998, pp. 341-346
Authors:
SOBRERO A
Citation: A. Sobrero, TALKING TOMUDEX - PROCEEDINGS OF AN INVESTIGATORS MEETING, MADRID, 19APRIL 1997, AND ADDITIONAL RELEVANT PAPERS - INTRODUCTION, Anti-cancer drugs, 8, 1997, pp. 1-3
Authors:
GUGLIELMI A
ASCHELE C
GROSSI F
TIXI L
SOBRERO A
Citation: A. Guglielmi et al., ALTERNATING BOLUS AND CONTINUOUS-INFUSION 5-FLUOROURACIL - A STRATEGYTO OVERCOME RESISTANCE TO THIS FLUOROPYRIMIDINE IN ADVANCED COLORECTAL-CANCER PATIENTS, Cytotechnology, 19(3), 1996, pp. 215-219
Authors:
GUGLIELMI A
ASCHELE C
MORI A
BALDO C
RUSSO P
DEBERNARDIS D
VALENTI M
BRUNO S
TAVERNA M
ROSSO R
SOBRERO A
Citation: A. Guglielmi et al., IN-VITRO SYNERGISM BETWEEN 5-FLUOROURACIL AND NATURAL BETA-INTERFERONIN HUMAN COLON-CARCINOMA CELLS, Clinical cancer research, 1(11), 1995, pp. 1337-1344
Authors:
SOBRERO A
ASCHELE C
GUGLIELMI A
MORI A
TIXI L
BOLLI E
GROSSI F
Citation: A. Sobrero et al., CIRCUMVENTION OF RESISTANCE TO 5-FLUOROURACIL BY SCHEDULE-ORIENTED BIOCHEMICAL MODULATION IN ADVANCED COLON-CANCER PATIENTS, European journal of cancer, 31A, 1995, pp. 305-305
Authors:
ASCHELE C
SOBRERO A
LOMBARDO C
SANTI L
Citation: C. Aschele et al., HOW UNIFORM ARE POSTGRADUATE TRAINING-PROGRAMS IN MEDICAL ONCOLOGY INTHE EUROPEAN UNION, Annals of oncology, 6(5), 1995, pp. 441-443
Authors:
ASCHELE C
GUGLIELMI A
MORI A
TIXI L
BOLLI E
CIFERRI E
FAZIO S
MUNICINO O
SOBRERO A
Citation: C. Aschele et al., THE 2 SIDES OF 5-FLUOROURACIL - BOLUS AND CONTINUOUS-INFUSION, Journal of experimental & clinical cancer research, 14(2), 1995, pp. 53-59
Authors:
BOLLI E
SACCOMANNO S
MONDINI G
ASCHELE C
GUGLIELMI A
LIGAS B
CONNIO M
MORI A
ROSSO R
SOBRERO A
TIXI L
PUGLIESE V
Citation: E. Bolli et al., 5-FLUOROURACIL PLUS 5-METHYLTETRAHYDROFOLATE IN ADVANCED PANCREATIC-CANCER, Cancer chemotherapy and pharmacology, 35(4), 1995, pp. 339-342
Authors:
ROSSO R
MAZZEI T
SOBRERO A
MINI E
CARTEI G
CONTE P
LABIANCA R
CARTEI F
FALCONE A
PANCERA G
BARSANTI G
DICOSTANZO F
GUGLIELMI A
BOLLI E
TIXI L
ASCHELE C
RIBECCO A
PERITI P
Citation: R. Rosso et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND THE NATURAL 1-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA, European journal of cancer, 30A(3), 1994, pp. 338-343
Authors:
BAJETTA E
COLLEONI M
ROSSO R
SOBRERO A
AMADORI D
COMELLA G
MARANGOLO M
SCANNI A
LORUSSO V
CALABRESI F
BONSIGNORI M
CRIVELLARI D
PASQUINI E
BRUZZI P
REPETTO M
CRISCUOLO D
Citation: E. Bajetta et al., PROSPECTIVE RANDOMIZED TRIAL COMPARING FLUOROURACIL VERSUS DOXIFLURIDINE FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER, European journal of cancer, 29A(12), 1993, pp. 1658-1663
Authors:
MORI A
BERTOGLIO S
GUGLIELMI A
ASCHELE C
BOLLI E
TIXI L
ROSSO R
SOBRERO A
Citation: A. Mori et al., ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 179-180
Authors:
WANG FS
ASCHELE C
SOBRERO A
CHANG YM
BERTINO JR
Citation: Fs. Wang et al., DECREASED FOLYLPOLYGLUTAMATE SYNTHETASE EXPRESSION - A NOVEL MECHANISM OF FLUOROURACIL RESISTANCE, Cancer research, 53(16), 1993, pp. 3677-3680
Authors:
ASCHELE C
SOBRERO A
FADERAN MA
BERTINO JR
Citation: C. Aschele et al., NOVEL MECHANISM(S) OF RESISTANCE TO 5-FLUOROURACIL IN HUMAN COLON CANCER (HCT-8) SUBLINES FOLLOWING EXPOSURE TO 2 DIFFERENT CLINICALLY RELEVANT DOSE SCHEDULES, Cancer research, 52(7), 1992, pp. 1855-1864
Risultati:
1-15
|